2-Chloro-10,11-dihydro-11-oxo-dibenzo[b,f][1,4]oxazepine

We are 2-Chloro-10,11-dihydro-11-oxo-dibenzo[b,f][1,4]oxazepine CAS:3158-91-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2-Chloro-10,11-dihydro-11-oxo-dibenzo[b,f][1,4]oxazepine
CAS.NO:3158-91-6
Synonyms:2-Chloro-10,11-dihydro-11-oxo-dibenzo[b,f][1,4]oxazepine
8-chloro-5H-benzo[b][1,4]benzoxazepin-6-one
2-Chlorodibenzo[b,f][1,4]oxazepin-11(10H)-one
 
Physical and Chemical Properties:
Density 1.369 g/cm3
Boiling Point 320.8ºC at 760 mmHg
Melting Point 242-244ºC
Molecular Formula C13H8ClNO2
Molecular Weight 245.66100
Flash Point 147.8ºC
 
Specification:
Appearance:Yellowish crystalline powde
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Amoxapine(CAS:14028-44-5/65576-45-6).

2-Chloro-10,11-dihydro-11-oxo-dibenzo[b,f][1,4]oxazepine


Related News: Cost: Hedge prices of thick product lines + self-produced intermediates fluctuate, and sufficient supply of upstream raw materials can significantly promote the production of APIs.156-87-6 This is very visible in herbal medicines in which the API is frequently a combination of several mixtures and/or substances which when used together cause pharmacological activity on the body.azetidin-3-one,hydrochloride The drug, Imfinzi, when added to chemotherapy and the drugmaker’s other cancer drug tremelimumab, significantly improved the survival of patients without the disease progressing, when compared to chemotherapy alone, the company said.3-Bromobenzaldehyde CAS:3132-99-8 The drug, Imfinzi, when added to chemotherapy and the drugmaker’s other cancer drug tremelimumab, significantly improved the survival of patients without the disease progressing, when compared to chemotherapy alone, the company said.A Phase 1/2 trial of the combination therapy has been fully enrolled, and the preliminary efficacy and safety data was presented at The American Society of Hematology (ASH) Annual Meeting in December 2018.

Related Products
Product Name
N-(tert-Butoxycarbonyl)-L-glutamine View Details
2-Bromo-5-fluorobenzoic acid View Details
N-methyl-2,4-dinitroaniline View Details
4-Pentylbenzeneboronic acid manufacturer 2-Bromo-3-fluorobenzoic acid manufacturer N-(biphenyl-4-yl)-N-(4′-broMobiphenyl-4-yl)-9,9-diMethyl-9H-fluoren-2-amine manufacturer ditert-butyl-(5-ditert-butylphosphanyl-9,9-dimethylxanthen-4-yl)phosphane manufacturer Lithium tetrakis(pentafluorophenyl)borate ethyl etherate manufacturer